Sensient Tech SEC Filings

On 30 June 2025, Sensient Technologies Corp. (SXT) director Dr. Joseph Carleone filed a Form 4 reporting the crediting of 370.737 deferred stock units under the company’s Directors’ Deferred Compensation Plan. These units convert to common stock on a one-for-one basis when his board service ends and carry no cash exercise price. After the accrual, Carleone’s direct beneficial ownership rises to 22,305.754 shares, up from 21,354.818 previously reported. No open-market purchase or sale occurred; the change stems solely from fee deferral. The transaction represents a <0.001% increase relative to SXT’s ~53 million shares outstanding and is therefore viewed as routine and immaterial to the company’s valuation or governance profile.

Sensient Technologies Corp. (SXT) filed a Form 4 on 1 July 2025 reporting that director Dr. Mario Ferruzzi acquired 55.116 deferred stock units on 30 June 2025 through the company’s Directors’ Deferred Compensation Plan. Each unit is economically equivalent to one share of common stock and will be issued when the director leaves the board. After this routine award, Ferruzzi’s holdings consist of 7,980.067 common shares held directly, 225.529 shares held indirectly via his spouse’s ESOP account, and 3,103.917 deferred stock units. No common shares were sold, and the transaction involved no cash outlay because it reflects a deferral of board fees rather than an open-market purchase.

Form 4 filing overview – Sensient Technologies Corp. (SXT)

Director Deborah McKeithan-Gebhardt reported a routine change to her equity position on 30 June 2025. The transaction involved the acquisition of 83.054 deferred stock units under the company’s Directors’ Deferred Compensation Plan. These units convert to common stock on a one-for-one basis and will be issued when the director’s board service ends.

Following the transaction, McKeithan-Gebhardt’s total beneficial ownership stands at 16,280.531 shares of common stock held directly and 5,468.395 deferred stock units, for an aggregated exposure of roughly 21,749 shares. No common shares were bought or sold in the open market, and no cash consideration was exchanged; the additional units reflect fee deferral rather than a discretionary share purchase.

The filing does not disclose any option grants, sales, or derivative disposals, and there are no indications of material changes to the insider’s overall ownership percentage or to the company’s capital structure. Given the small size of the award (≈0.002% of SXT’s ~45 million shares outstanding), the transaction is considered routine and non-material from a liquidity or control standpoint. However, the directionally positive addition may still be interpreted by some investors as a signal of ongoing board alignment with shareholder interests.

National Vision Holdings, Inc. (EYE) – Form 4 insider filing dated 06/23/2025

Director Caitlin Zulla reported the grant of 10,870 restricted stock units (RSUs) on 06/18/2025. Each RSU converts into one share of common stock and vests in full on the first anniversary of the grant. No cash consideration was paid (grant price $0). Following the award, the director’s total beneficial ownership stands at 21,880 shares, all held directly.

• Form indicates a single reporting person and no derivative transactions beyond the RSU grant.
• Transaction was coded “A” (award) and does not appear to be part of a Rule 10b5-1 trading plan.
• No amendments, sales, or dispositions were disclosed.

This filing reflects routine board compensation and does not signal any strategic shift or imminent corporate event.